A Multicenter, Open-Label, Randomized Phase 2a Study to Evaluate Safety and Efficacy of Ratutrelvir and Standard of Care in Non-hospitalized Symptomatic Adult Participants With Mild to Moderate COVID-19

CONDITION

Infection

GENDER

Both males and females

AGE GROUP

From 18

and above

STATUS

Closed: follow-up complete

This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19. It will also learn about the safety of drug Ratutrelvir. Participants will take a study drug as well as a standard therapy. A descriptive statistics will be used to present the study results.

CONTACT DETAILS

Clinical Trial Site: Clinical Trials Institute
Phone Number: (03) 4252 7023 Email: Info@clinicaltrialsinstitute.com.au Location: 101/1 Cylinders Drive, Torquay VIC, Australia

Studies Contact Form

Approved By: Bellberry              

Clinical Trial Registry Link: Click Here


Notice: Function WP_Scripts::add was called incorrectly. The script with the handle "gforms_recaptcha_frontend" was enqueued with dependencies that are not registered: gforms_recaptcha_recaptcha. Please see Debugging in WordPress for more information. (This message was added in version 6.9.1.) in /srv/users/australianclinicaltrials/apps/australianclinicaltrials/public/wp-includes/functions.php on line 6260